These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 14576480)
1. Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma. Loddenkemper C; Mechsner S; Foss HD; Dallenbach FE; Anagnostopoulos I; Ebert AD; Stein H Am J Surg Pathol; 2003 Nov; 27(11):1458-62. PubMed ID: 14576480 [TBL] [Abstract][Full Text] [Related]
2. Use of myocardin in the classification of mesenchymal tumors of the uterus. Liang J; Wu L; Xiao H; Li N; Wang H; Cheng C; Bai R; Zhao Y; Zheng H Int J Gynecol Pathol; 2010 Jan; 29(1):55-62. PubMed ID: 19952936 [TBL] [Abstract][Full Text] [Related]
3. h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma. Rush DS; Tan J; Baergen RN; Soslow RA Am J Surg Pathol; 2001 Feb; 25(2):253-8. PubMed ID: 11176075 [TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies. Oliva E; Young RH; Amin MB; Clement PB Am J Surg Pathol; 2002 Apr; 26(4):403-12. PubMed ID: 11914617 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma. Zhu XQ; Shi YF; Cheng XD; Zhao CL; Wu YZ Gynecol Oncol; 2004 Jan; 92(1):71-9. PubMed ID: 14751141 [TBL] [Abstract][Full Text] [Related]
7. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Chu PG; Arber DA; Weiss LM; Chang KL Mod Pathol; 2001 May; 14(5):465-71. PubMed ID: 11353058 [TBL] [Abstract][Full Text] [Related]
8. Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterus. de Leval L; Waltregny D; Boniver J; Young RH; Castronovo V; Oliva E Am J Surg Pathol; 2006 Mar; 30(3):319-27. PubMed ID: 16538051 [TBL] [Abstract][Full Text] [Related]
9. CD10 imunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis. Srodon M; Klein WM; Kurman RJ Am J Surg Pathol; 2003 Jun; 27(6):786-9. PubMed ID: 12766582 [TBL] [Abstract][Full Text] [Related]
10. Epithelioid endometrial and endometrioid stromal tumors: a report of four cases emphasizing their distinction from epithelioid smooth muscle tumors and other oxyphilic uterine and extrauterine tumors. Oliva E; Clement PB; Young RH Int J Gynecol Pathol; 2002 Jan; 21(1):48-55. PubMed ID: 11781523 [TBL] [Abstract][Full Text] [Related]
11. Endometrial stromal neoplasms are immunoreactive with WT-1 antibody. Sumathi VP; Al-Hussaini M; Connolly LE; Fullerton L; McCluggage WG Int J Gynecol Pathol; 2004 Jul; 23(3):241-7. PubMed ID: 15213600 [TBL] [Abstract][Full Text] [Related]
12. Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry. Mills AM; Beck AH; Montgomery KD; Zhu SX; Espinosa I; Lee CH; Subramanian S; Fletcher CD; van de Rijn M; West RB Am J Surg Pathol; 2011 Apr; 35(4):583-9. PubMed ID: 21412072 [TBL] [Abstract][Full Text] [Related]
13. Transgelin, a Novel Marker of Smooth Muscle Differentiation, Effectively Distinguishes Endometrial Stromal Tumors from Uterine Smooth Muscle Tumors. Tawfik O; Rao D; Nothnick WB; Graham A; Mau B; Fan F Int J Gynecol Obstet Reprod Med Res; 2014 Sep; 1(1):26-31. PubMed ID: 26023684 [TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical study of endometrial stromal sarcoma and smooth-muscle tumors of the uterus]. Farah-Klibi F; Ben Hamouda S; Ben Romdhane S; Sfar R; Koubaa A; Ben Jilani S; Zermani R J Gynecol Obstet Biol Reprod (Paris); 2008 Sep; 37(5):457-62. PubMed ID: 18565690 [TBL] [Abstract][Full Text] [Related]
15. Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation. Yilmaz A; Rush DS; Soslow RA Am J Surg Pathol; 2002 Sep; 26(9):1142-50. PubMed ID: 12218570 [TBL] [Abstract][Full Text] [Related]
16. IFITM1 Outperforms CD10 in Differentiating Low-grade Endometrial Stromal Sarcomas From Smooth Muscle Neoplasms of the Uterus. Busca A; Gulavita P; Parra-Herran C; Islam S Int J Gynecol Pathol; 2018 Jul; 37(4):372-378. PubMed ID: 28700435 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical panel to differentiate endometrial stromal sarcoma, uterine leiomyosarcoma and leiomyoma: something old and something new. Hwang H; Matsuo K; Duncan K; Pakzamir E; Pham HQ; Correa A; Fedenko A; Mhawech-Fauceglia P J Clin Pathol; 2015 Sep; 68(9):710-7. PubMed ID: 25991737 [TBL] [Abstract][Full Text] [Related]
18. [Highly cellular leiomyoma of uterus: a comparative morphologic and immunohistochemical study of endometrial stromal tumors]. Liao X; Wang Y; Yue C; Liu Y; Wang H; Dai L; Hui Y Zhonghua Bing Li Xue Za Zhi; 2002 Oct; 31(5):396-400. PubMed ID: 12485478 [TBL] [Abstract][Full Text] [Related]
19. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. McCluggage WG; Sumathi VP; Maxwell P Histopathology; 2001 Sep; 39(3):273-8. PubMed ID: 11532038 [TBL] [Abstract][Full Text] [Related]
20. [Myxoid mesenchymal tumors of uterus: endometrial stromal and smooth muscle tumors, myxoid variant]. Chesnais AL; Watkin E; Beurton D; Devouassoux-Shisheboran M Ann Pathol; 2011 Jun; 31(3):152-8. PubMed ID: 21736994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]